Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The role of allergies(A)and tobacco exposure(T)in Obstructive Sleep Apnea Syndrome(OSAS)Type I/II(I/II)in children, and Sublingual Immunotherapy(SLIT)for the treatment of children with OSAS I/II with an Allergic Profile(AP)

K Kefala, P Guerin
ERJ Open Research 2021 7: 39; DOI: 10.1183/23120541.sleepandbreathing-2021.39
K Kefala
1Fondation Oeuvre De La Croix Saint-Simon,CSMD Clavel & Clinique Lambert, Ramsay Générale de Santé, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Guerin
2Clinique du Souffle,Les Clarins, Riom-Es-Montagnes, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 7 no. suppl 7
DOI 
https://doi.org/10.1183/23120541.sleepandbreathing-2021.39

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Published online May 3, 2021.

Copyright & Usage 
Copyright ©the authors 2021

Author Information

  1. K Kefala1⇑ and
  2. P Guerin2
  1. 1Fondation Oeuvre De La Croix Saint-Simon,CSMD Clavel & Clinique Lambert, Ramsay Générale de Santé, Paris, France
  2. 2Clinique du Souffle,Les Clarins, Riom-Es-Montagnes, France
  1. K Kefala, Fondation Oeuvre De La Croix Saint-Simon,CSMD Clavel & Clinique Lambert, Ramsay Générale de Santé, Paris, France.

Article usage

Article usage: May 2021 to July 2022

AbstractFullPdf
May 20213600
Jun 20211000
Jul 20211300
Aug 2021600
Sep 20211500
Oct 20211400
Nov 2021900
Dec 2021800
Jan 20221700
Feb 2022700
Mar 2022700
Apr 2022500
May 2022600
Jun 2022600
Jul 2022600

Altmetrics

Next
Back to top
Vol 7 Issue suppl 7 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of allergies(A)and tobacco exposure(T)in Obstructive Sleep Apnea Syndrome(OSAS)Type I/II(I/II)in children, and Sublingual Immunotherapy(SLIT)for the treatment of children with OSAS I/II with an Allergic Profile(AP)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The role of allergies(A)and tobacco exposure(T)in Obstructive Sleep Apnea Syndrome(OSAS)Type I/II(I/II)in children, and Sublingual Immunotherapy(SLIT)for the treatment of children with OSAS I/II with an Allergic Profile(AP)
K Kefala, P Guerin
ERJ Open Research Apr 2021, 7 (suppl 7) 39; DOI: 10.1183/23120541.sleepandbreathing-2021.39

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The role of allergies(A)and tobacco exposure(T)in Obstructive Sleep Apnea Syndrome(OSAS)Type I/II(I/II)in children, and Sublingual Immunotherapy(SLIT)for the treatment of children with OSAS I/II with an Allergic Profile(AP)
K Kefala, P Guerin
ERJ Open Research Apr 2021, 7 (suppl 7) 39; DOI: 10.1183/23120541.sleepandbreathing-2021.39
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy
  • Nocturnal oxygen saturation parameters as predictive factors for DM2 among OSA patients
  • Referral to a sleep laboratory from primary care – are family doctors on the right track?
Show more Sleep & Breathing disorders

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2022 by the European Respiratory Society